Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Vulnerable Plaques

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

A Brief Review of the Concept and Proposed Approaches to Diagnosis and Treatment

Technology Assessment

The technology assessment program at the Agency for Healthcare Research and Quality (AHRQ) provides technology assessments for the Centers for Medicare & Medicaid Services (CMS). These technology assessments are used by CMS to inform its national coverage decisions for the Medicare program as well as provide information to Medicare carriers.

AHRQ's technology assessment program uses state-of-the-art methodologies for assessing the clinical utility of medical interventions. Technology assessments are based on a systematic review of the literature, along with appropriate qualitative and quantitative methods of synthesizing data from multiple studies.

Select for PDF Version (460 KB). PDF Help.


Current Concept of Vulnerable Plaque
Natural History
Proposed Methods To Identify Vulnerable Plaque
Implications for Patient Management
Appendix 1
Appendix 2

Prepared for AHRQ under Contract No. 290-02-0022. By Joseph Lau, M.D., David Kent, M.D., Athina Tatsioni, M.D., et al; Tufts-New England Medical Center Evidence-based Practice Center.

Current as of January 2004

The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care